Republican Senators: FDA Must Expand Scope Of Drug Parallel Track

By David Roza / May 21, 2019 at 2:47 PM
Republican senators call on FDA to expand access to investigational drugs to treat Alzheimer’s, cancer and amyotrophic lateral sclerosis (ALS) by widening the scope of a generations-old Parallel Track program that currently grants only patients with AIDS and other HIV-related diseases access to certain drugs shown to be safe but which haven’t completed FDA efficacy trials. The lawmakers, some of whom also co-sponsored right-to-try legislation, said the move would increase patient access to life-saving drugs and therapies and lower costs...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.